Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05272475 · ClinicalTrials.gov registry record · NA
The Acute Effects of Chamomile Intake on Blood Coagulation Tests in Healthy Volunteers
A NA study, sponsored by Stony Brook University.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT05272475: Completed NA study, sponsored by Stony Brook University.
NCT05272475 is a NA study that has completed, run by Stony Brook University. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05272475, a NA study, has completed, sponsored by Stony Brook University.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
Chamomile may possess anticoagulant effects based on the presence of coumarin-like compounds within the flower. This randomized complete crossover study will investigate the impact of chamomile ingestion acutely on coagulation.
Interventions
- DIETARY_SUPPLEMENT Chamomile Tea
- DIETARY_SUPPLEMENT Chamomile Extract Capsule
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2022-03-16 |
| Est. Completion | 2022-05-12 |
| Phase | NA |
What the finished NCT05272475 record still lists
NCT05272475 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Chamomile Tea is the first listed.
NCT05272475 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05272475 about?
NCT05272475 is a clinical study titled "The Acute Effects of Chamomile Intake on Blood Coagulation Tests in Healthy Volunteers". Chamomile may possess anticoagulant effects based on the presence of coumarin-like compounds within the flower. This randomized complete crossover study will investigate the impact of chamomile ingestion acutely on coagulation.
What is the current status of trial NCT05272475?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2022-03-16. Estimated completion is 2022-05-12.
What interventions are being tested in trial NCT05272475?
The interventions under investigation include: Chamomile Tea (DIETARY_SUPPLEMENT), Chamomile Extract Capsule (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05272475?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05272475's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI